0001171843-17-007192.txt : 20171121 0001171843-17-007192.hdr.sgml : 20171121 20171121060447 ACCESSION NUMBER: 0001171843-17-007192 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171120 FILED AS OF DATE: 20171121 DATE AS OF CHANGE: 20171121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowe Jeffrey M CENTRAL INDEX KEY: 0001619009 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38298 FILM NUMBER: 171215333 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734)369-2555 MAIL ADDRESS: STREET 1: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 3 1 form3rowe.xml OWNERSHIP DOCUMENT X0206 3 2017-11-20 0 0001684144 Zomedica Pharmaceuticals Corp. ZOM 0001619009 Rowe Jeffrey M C/O ZOMEDICA PHARMACEUTICALS CORP. 3928 VARSITY DRIVE ANN ARBOR MI 48018 1 0 1 0 Common Shares, without par value 664480 I By Jeffrey M. Rowe Living Trust Common Shares, without par value 11120000 I By Rowe Family GST Trust Common Shares, without par value 181000 I By IRA Stock Option (right to buy) 0.20 2016-03-28 2018-04-21 Common Shares, without par value 100000 D Stock Option (right to buy) 1.20 2016-12-21 2018-12-21 Common Shares, without par value 175000 D The reporting person serves as Trustee. Reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Reporting Person's sister serves as trustee with reporting person's oversight. Reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The options vested upon grant. The option is currently fully vested. Exhibit List Exhibit 24 - Power of Attorney /s/ John D. Hogoboom, attorney-in-fact 2017-11-20 EX-24 2 exh_24.htm POWER OF ATTORNEY

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Gerald Solensky, Jr., Shameze Rampertab, John Hogoboom, Jennifer Dressler and Stephen Zapf his true and lawful attorney-in-fact to:

 

1.execute for and on behalf of the undersigned Schedules 13D and 13G, Form ID, and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder;

 

2.do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Schedules 13D or 13G, Form ID application for EDGAR codes, and Forms 3, 4 or 5, and the timely filing of such Forms with the United States Securities and Exchange Commission and any other authority; and

 

3.take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, including, without limitation, the execution and filing of a Form 4 with respect to a transaction which may be reported on a Form 5, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as he might or could do in person, with full power of substitution and resubstitution, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Sections 13 and 16 of the Exchange Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Schedules 13D and 13G and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Exchange Act and the rules thereunder with respect to the undersigned's holdings of and transactions in securities issued by Zomedica Pharmaceuticals Corp., unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this __30__ day of October, 2017.

 

  /s/ Jeffrey Rowe  
  By: Jeffrey Rowe